Evidence map›Paper›PMID 26427752›Full record

ArticleJournal of experimental & clinical cancer research : CR2015

Erratum to: Intermittent high dose proton pump inhibitor enhances the antitumor effects of chemotherapy in metastatic breast cancer.

Bi-Yun Wang, Jian Zhang, Jia-Lei Wang, Si Sun, Zhong-Hua Wang, Lei-Ping Wang, Qun-Ling Zhang, Fang-Fang Lv, En-Ying Cao, Zhi-Min Shao and 2 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of experimental & clinical cancer research : CR, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. Targeting tumor-associated acidity in cancer immunotherapy.Cancer immunology, immunotherapy : CII · 2018
    Review
  4. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors.

Bi-Yun WangDepartment of Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai, China.
Jian ZhangDepartment of Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai, China.
Jia-Lei WangDepartment of Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai, China.
Si SunDepartment of Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai, China.
Zhong-Hua WangDepartment of Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai, China.
Lei-Ping WangDepartment of Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai, China.
Qun-Ling ZhangDepartment of Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai, China.
Fang-Fang LvDepartment of Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai, China.
En-Ying CaoDepartment of Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai, China.
Zhi-Min ShaoDepartment of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
Stefano FaisAnti-Tumour Drugs Section, Department of Therapeutic Research and Medicines Evaluation, National Institute of Health, Rome, Italy. stefano.fais@iss.it.
Xi-Chun HuDepartment of Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai, China. huxicun@gmail.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID26427752
PMCPMC4589907

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.